Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron May 04, 2021 7:28pm

39 Views

Post# 33129236

todays trades

House Positions for C:VXL from 20210504 to 20210504

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
1 Anonymous	29,000	3,395	0.117	1,745	205	0.117	27,255	-3,190
33 Canaccord	30,000	3,450	0.115	11,500	1,380	0.12	18,500	-2,070
2 RBC	34,245	3,988	0.116	17,000	1,957	0.115	17,245	-2,031
68 Leede	5,620	646	0.115	300	36	0.12	5,320	-610
14 ITG	4,000	480	0.12	0			4,000	-480
80 National Bank	90,730	10,522	0.116	89,650	10,393	0.116	1,080	-129
85 Scotia	1,000	120	0.12	2,119	243	0.115	-1,119	123
124 Questrade	1,000	115	0.115	12,500	1,437	0.115	-11,500	1,322
7 TD Sec	71,621	8,510	0.119	87,127	10,374	0.119	-15,506	1,864
79 CIBC	5,925	688	0.116	51,200	5,887	0.115	-45,275	5,199
TOTAL	273,141	31,914	0.117	273,141	31,912	0.117	0	-2